US 12,466,801 B2
Cannabichromene derivatives and use thereof
Wayne Wesley Harding, New York, NY (US); and Hari Krishna Namballa, New York, NY (US)
Assigned to Remedy Processors LLC, San Diego, CA (US)
Filed by Remedy Processors LLC, San Diego, CA (US)
Filed on Mar. 4, 2025, as Appl. No. 19/069,464.
Application 19/069,464 is a continuation of application No. PCT/US2024/012116, filed on Jan. 19, 2024.
Claims priority of provisional application 63/541,044, filed on Sep. 28, 2023.
Claims priority of provisional application 63/541,063, filed on Sep. 28, 2023.
Claims priority of provisional application 63/541,061, filed on Sep. 28, 2023.
Claims priority of provisional application 63/440,344, filed on Jan. 20, 2023.
Prior Publication US 2025/0243175 A1, Jul. 31, 2025
Int. Cl. C07D 311/58 (2006.01); A61K 31/00 (2006.01); A61P 35/00 (2006.01)
CPC C07D 311/58 (2013.01) [A61K 31/658 (2023.05); A61P 35/00 (2018.01)] 11 Claims
OG exemplary drawing
 
1. A compound or a pharmaceutically acceptable salt or a stereoisomer thereof according to Formula I:

OG Complex Work Unit Chemistry
wherein:
wherein: R1 is alkyl, cycloalkyl, or aryl, wherein alkyl, cycloalkyl, or aryl groups may be substituted with hydroxy, alkoxy, halogen, nitro, carboxy, alkyl, aryl, and sulfonic acid.